Axios @axios
Pfizer cannot directly or indirectly pay out-of-pocket costs for Medicare patients to get the company's $225,000-a-year heart drug because doing so would violate federal kickback law, a U.S. district judge ruled. https://t.co/8d0ACqq6PG — PolitiTweet.org